The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment
Abstract
Increasing numbers of studies indicate that free radicals and their derivatives play a role in some neuropsychiatric disorders, such as depression. The aim of this study was to investigate the activities of antioxidant enzymes, lipid peroxidation and total antioxidant status (TAS) in patients suffering from major depressive disorder (MDD) as compared to healthy controls. Specifically, we wanted to estimate how fluoxetine influences antioxidant defense and lipid peroxidation. Fifty MDD patients and thirty healthy controls participated in the study. Antioxidant enzyme activities and lipid peroxidation levels were measured in erythrocytes, while TAS was measured in plasma. All measurements were taken during an acute depressive episode and then again during depression remission after a three-month fluoxetine treatment. During acute depressive episodes, patients had significantly higher activity levels of antioxidant enzymes, such as copper-zinc superoxide dismutase (SOD1) and catalase (CAT), as compared to healthy controls. Concentrations of malondialdehyde (MDA) were also significantly higher during depressive episodes. Activity levels of glutathione peroxidase (GPx) did not differ significantly between depressed patients and healthy control subjects. Moreover, the plasma total antioxidant status of the depressed patients was decreased in comparison to control subjects. After three months of fluoxetine treatment, the above parameters did not change significantly. Major depressive disorder is accompanied by disturbances in the balance between pro- and anti-oxidative processes; however, these disturbances do not improve in patients in remission after three months of fluoxetine therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“or a significant increase in most of the studies [123, 124, 128, 129].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [124]
In the citing paper
“Also, when the modification of oxidative stress markers was followed in patients with depressive disorder after fluoxetine administration for three months, it was found that the levels of some antioxidant enzymes like Cu/Zn-SOD and CAT are significantly higher in the patients group versus the controls [124].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [124]
In the citing paper
“Individuals who suffer with MDD display lower serum/plasmatic total antioxidant potentials [28, 32, 48] and reduced brain GSH levels [31] as compared to matched controls.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [48]
In the citing paper
“Before treatment, MDD patients displayed increased erythrocyte SOD and CAT activities, increased MDA levels, and decreased plasmatic total antioxidant status (TAS) level.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [48]
In the citing paper
“After three months of fluoxetine treatment, MDA levels were normalized [48].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [48]
Citations
Cites
1 retracted
Hwang, E., & Kim, G. (2006) · Toxicology · doi:10.1016/j.tox.2006.10.013 · Cited by 149
RetractedHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
Benzie, I. F. F., & Strain, J. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0292 · Cited by 23,027
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Misra, H. P., & Fridovich, I. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45228-9 · Cited by 9,097
A SPECTROPHOTOMETRIC METHOD FOR MEASURING THE BREAKDOWN OF HYDROGEN PEROXIDE BY CATALASE
Beers, R. F., & Sizer, I. W. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50881-x · Cited by 6,781
Benzie, I. F. F., & Strain, J. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)99005-5 · Cited by 3,940
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Rio, D. D., Stewart, A. J., & Pellegrini, N. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.003 · Cited by 2,789
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems
Placer, Z., Cushman, L. L., & Johnson, B. C. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90167-9 · Cited by 2,330
Lipid peroxidation and antioxidants as biomarkers of tissue damage
Gutteridge, J. M. C. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1819 · Cited by 1,849
Ellsworth, P. D. (1980) · American Journal of Occupational Therapy · doi:10.5014/ajot.34.12.819a · Cited by 1,702
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Nitric oxide and superoxide in inflammation and immune regulation.
Guzik, T. J., Korbut, R., & Adamek-Guzik, T. (2003) · PubMed · Cited by 1,096
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931
In vivo total antioxidant capacity: comparison of different analytical methods1
Prior, R. L., & Cao, G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00203-8 · Cited by 925
Lipid peroxidation: Mechanisms, inhibition, and biological effects
Niki, E., Yoshida, Y., Saito, Y., & Noguchi, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.072 · Cited by 877
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function
Fialkow, L., Wang, Y., & Downey, G. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.030 · Cited by 723
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Oxidative stress markers in bipolar disorder: A meta-analysis
Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526
Sarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486
Stress and depression: possible links to neuron death in the hippocampus
Lee, A. L., Ogle, W. O., & Sapolsky, R. M. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01144.x · Cited by 470
Cytokines as mediators of depression: what can we learn from animal studies?
Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459
Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458
Maes, M. H. J., Christophe, A. B., Delanghe, J., Altamura, C. A., Neels, H. M., & Meltzer, H. Y. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00014-1 · Cited by 452
An intracellular GSH-peroxidase with a lipid peroxide substrate
Little, C., & O'Brien, P. J. (1968) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(68)90721-3 · Cited by 445
Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia
Rao, A. M., & Hatcher, J. F. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.044 · Cited by 392
Phospholipase A2 in the central nervous system
Sun, G. Y., Xu, J., Jensen, M. D., & Simonyi, Á. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300016-jlr200 · Cited by 391
Antioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368
Karihtala, P., & Soini, Y. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_514.x · Cited by 352
Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders
McEwen, B. S., & Magarinos, A. M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.266 · Cited by 349
Inflammation, Depression and Dementia: Are they Connected?
Leonard, B. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9385-y · Cited by 342
The immune system, depression and the action of antidepressants
Leonard, B. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00155-5 · Cited by 333
Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322
Serum S100B and antioxidant enzymes in bipolar patients
Andreazza, A. C., Cassini, C., Rosa, A. R., Leite, M. C., de Almeida, L. M. V., Nardin, P., da Cunha, A. B., Ceresér, K. M. M., Santin, A. M. P., Gottfried, C., et al. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.013 · Cited by 307
The monocyte-T-lymphocyte hypothesis of major depression
Maes, M., Smith, R., & Simon, S. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00066-j · Cited by 299
Lower serum vitamin E concentrations in major depression
Maes, M. H. J., Vos, N. D., Pioli, R., Demedts, P., Wauters, A., Neels, H. M., & Christophe, A. B. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00121-4 · Cited by 274
Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid
Winterbourn, C. C. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00286-x · Cited by 247
Macrophages and neurodegeneration
Hendriks, J. J. A., Teunissen, C. E., de Vries, H. E., & Dijkstra, C. D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.008 · Cited by 247
Kunz, M., Gama, C. S., Andreazza, A. C., Salvador, M. M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. P. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 245
Brustolim, D., Ribeiro‐dos‐Santos, R., Kast, R. E., Altschuler, E. L., & Soares, M. B. P. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2005.12.007 · Cited by 195
Oxidative stress and arachidonic acid mobilization
Balboa, M. A., & Balsinde, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.014 · Cited by 191
Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats
Zafir, A., & Banu, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.062 · Cited by 156
Kubera, M., Maes, M. H. J., Kenis, G., Kim, Y., & Lasoń, W. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.01.014 · Cited by 146
Sengpiel, B., Preis, E., Krieglstein, J., & Prehn, J. H. M. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00202.x · Cited by 144
Selley, M. L. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00135-6 · Cited by 139
Fluoxetine tenth anniversary update: the progress continues
Stokes, P. E., & Holtz, A. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80066-5 · Cited by 136
Assessment of lifestyle effects on the overall antioxidant capacity of healthy subjects.
Lesgards, J., Durand, P., Lassarre, M., Stocker, P., Lesgards, G., Lanteaume, A., Prost, M., & Lehucher‐Michel, M. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110479 · Cited by 135
Increased DNA damage and oxidative stress in patients with rheumatoid arthritis
Altındağ, Ö., Karakoç, M. A., Koçyiğit, A., Çelık, H., & Soran, N. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.10.006 · Cited by 127
Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants
Tsuboi, H., Tatsumi, A., Yamamoto, K., Kobayashi, F., Shimoi, K., & Kinae, N. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.010 · Cited by 119
Özgöçmen, S., Özyurt, H., Söğüt, S., Akyol, Ö., Ardıçoğlu, Ö., & Yildizhan, H. (2005) · Rheumatology International · doi:10.1007/s00296-005-0079-y · Cited by 117
Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide
Kolla, N. J., Wei, Z., Richardson, J. S., & Li, X. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0528 · Cited by 111
Activation of human inflammatory cells by secreted phospholipases A2
Triggiani, M., Granata, F., Frattini, A., & Marone, G. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.003 · Cited by 107
y Keenoy, B. M., Moorkens, G. H., Vertommen, J., Noe, M., Nève, J., & Leeuw, I. D. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718934 · Cited by 100
When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?
Quitkin, F. M., Petkova, E., McGrath, P. J., Taylor, B. P., Beasley, C. M., Stewart, J. W., Amsterdam, J. D., D, M. F. M., Rosenbaum, J. F., Reimherr, F. W., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.734 · Cited by 100
Schiepers, O. J. G., Wichers, M., & Maes, M. H. J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.02.001 · Cited by 97
Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation
Im, J., Kim, D., Paik, S., & Han, P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.06.001 · Cited by 94
Depression History, Stress, and Pain in Rheumatoid Arthritis Patients
Zautra, A., Parrish, B. P., Puymbroeck, C. M. V., Tennen, H. A., Davis, M. C., Reich, J. W., & Irwin, M. (2007) · Journal of Behavioral Medicine · doi:10.1007/s10865-007-9097-4 · Cited by 85
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A., Nag, D., Seth, P. K., Srimal, R. C., & Dikshit, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00421-9 · Cited by 80
Kim, D. H., Li, H., Yoo, K., Lee, B., Hwang, I. K., & Won, M. H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.008 · Cited by 77
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment
Atmaca, M., Tezcan, E., Kuloglu, M., Ustundag, B., & Tunckol, H. (2004) · European Archives of Psychiatry and Clinical Neurosciences · doi:10.1007/s00406-004-0484-3 · Cited by 75
Sarandöl, A., Sarandöl, E., Eker, S. S., Karaagac, E. U., Hizli, B., Dirican, M., & Kırlı, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.012 · Cited by 64
Ha, E., Jung, K. H., Choe, B., Bae, J., Shin, D.-H., Yim, S., & Baik, H. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.022 · Cited by 60
Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy
Sofic, E., Rustembegovic, A., Kroyer, G., & Cao, G. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200059 · Cited by 56
Treatment-Resistant Mood Disorders
Wolpe, P. R., & Caplan, A. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511666421 · Cited by 48
Li, Y., & Zhang, J. (2007) · Nutritional Neuroscience · doi:10.1080/10284150701250747 · Cited by 40
Skibska, B., Józefowicz-Okonkwo, G., & Gorąca, A. (2006) · PubMed · Cited by 39
[Regulation of human neutrophil oxidative burst by pro- and anti-inflammatory cytokines].
Gougerot‐Pocidalo, M., Benna, J. E., Elbim, C., Chollet‐Martin, S., & Dang, M.-C. (2002) · PubMed · Cited by 38
Gougerot‐Pocidalo, M., Benna, J. E., Elbim, C., Chollet‐Martin, S., & Dang, M. C. (2002) · Journal de la Société de Biologie · doi:10.1051/jbio/2002196010037 · Cited by 36
Gałecki, P., Kędziora, J., Florkowski, A., & Gałecka, E. (2007) · PubMed · Cited by 16
Self-citationInfluence of antidepressant drugs on macrophage cytotoxic activity in rats.
Belowski, D., Kowalski, J., Madej, A., & Herman, Z. S. (2004) · PubMed · Cited by 14
Role of Cytokines in Depression
Faith, R. E., Murgo, A. J., Good, R. A., & Plotnikoff, N. P. (2006) · CRC Press eBooks · doi:10.1201/9781420003802-8 · Cited by 13
Transtornos de humor refratários a tratamento
Machado‐Vieira, R., & Soares, J. C. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462006005000058 · Cited by 12
Research works printed but not linked: 1
- Bartosz, 2004, Other face of oxygen (Polish). PWN, Warsaw, 389
Cited by
Sorted by citations
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citationRole of oxidative stress in depression
Bhatt, S., Nagappa, A. N., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.001 · Cited by 854
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444
Metadata
- Authors
- Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E.
- Affiliations
- Medical University of Lodz (PL)
- Corresponding author
- Gałecki, Piotr
- Venue
- Pharmacological Reports
- Published
- 2009-05
- Volume
- 61
- Issue
- 3
- Pages
- 436-447
- ISSN
- 1734-1140 (ISSN-L)
- OpenAlex
- W2062447292
- Cited by
- 214
- References
- 78
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 10 · 2020: 17 · 2019: 13 · 2018: 16 · 2017: 13 · 2016: 14 · 2015: 20 · 2014: 19 · 2013: 10 · 2012: 17
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacological Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, lipid peroxidation, antioxidant enzymes, fluoxetine, depression remission, superoxide dismutase, catalase, glutathione peroxidase, malondialdehyde, total antioxidant status, free radicals, erythrocytes, plasma
- MeSH terms
- Acute Disease, Adult, Antioxidants, Major Depressive Disorder, Female, Fluoxetine, Humans, Male, Malondialdehyde, Lipid Peroxidation, Case-Control Studies, Selective Serotonin Reuptake Inhibitors, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
